Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation.

Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Abstract Text:

    giovanni g camiciGiovanni G Camici,thomas stallmachThomas Stallmach,matthias hermannMatthias Hermann,rutger hassinkRutger Hassink,peter doevendansPeter Doevendans,beat grenacherBeat Grenacher,alain hirschyAlain Hirschy,johannes vogelJohannes Vogel,thomas f Thomas F ,frank ruschitzkaFrank Ruschitzka,max gassmannMax Gassmann,giovanni g camiciGiovanni G Camici,thomas stallmachThomas Stallmach,matthias hermannMatthias Hermann,rutger hassinkRutger Hassink,peter doevendansPeter Doevendans,beat grenacherBeat Grenacher,alain hirschyAlain Hirschy,johannes vogelJohannes Vogel,thomas f Thomas F ,frank ruschitzkaFrank Ruschitzka,max gassmannMax Gassmann,

    In view of the emerging role of recombinant human erythropoietin (rhEPO) as a novel therapeutical approach in myocardial ischemia, we performed the first two-way parallel comparison to test the effects of rhEPO pretreatment (1000 U/kg, 12h before surgery) versus EPO transgenic overexpression in a mouse model of myocardial infarction. Unlike EPO transgenic mice who doubled their hematocrit, rhEPO pretreated mice maintained an unaltered hematocrit, thereby offering the possibility to discern erythropoietic-dependent from erythropoietic-independent protective effects of EPO. Animals pretreated with rhEPO as well as EPO transgenic mice underwent permanent left anterior descending (LAD) coronary artery ligation. Resulting infarct size was determined 24h after LAD ligation by hematoxylin/eosin staining, and morphometrical analysis was performed by computerized planimetry. A large reduction in infarction size was observed in rhEPO-treated mice (-74% +/- 14.51; P = 0.0002) and an even more pronounced reduction in the EPO transgenic group (-87% +/- 6.31; P < 0.0001) when compared to wild-type controls. Moreover, while searching for novel early ischemic markers, we analyzed expression of hypoxia-sensitive Wilms' tumor suppressor gene (WT1) in infarcted hearts. We found that its expression correlated with the infarct area, thereby providing the first demonstration that WT1 is a useful early marker of myocardial infarction. This study demonstrates for the first time that, despite high hematocrit levels, endogenously overexpressed EPO provides protection against myocardial infarction in a murine model of permanent LAD ligation.

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Publishing Authors By Initials

    gg camiciGG Camici,t stallmachT Stallmach,m hermannM Hermann,r hassinkR Hassink,p doevendansP Doevendans,b grenacherB Grenacher,a hirschyA Hirschy,j vogelJ Vogel,tf TF ,f ruschitzkaF Ruschitzka,m gassmannM Gassmann,gg camiciGG Camici,t stallmachT Stallmach,m hermannM Hermann,r hassinkR Hassink,p doevendansP Doevendans,b grenacherB Grenacher,a hirschyA Hirschy,j vogelJ Vogel,tf TF ,f ruschitzkaF Ruschitzka,m gassmannM Gassmann,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Methods in enzymology

    VOLUME: 435

    Page Numbers: 147-55

    Journal Abbreviation:

    ISSN: 0076-6879

    DAY: 13

    MONTH: 11

    YEAR: 2007

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 212271

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation.

    AFFILIATION: Cardiology and Cardiovascular Research and Institute of Physiology, University of Zürich, Zürich, Switzerland.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Methods Enzymol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News